Viewing Study NCT00445692


Ignite Creation Date: 2025-12-24 @ 3:48 PM
Ignite Modification Date: 2026-02-17 @ 7:36 PM
Study NCT ID: NCT00445692
Status: COMPLETED
Last Update Posted: 2019-11-13
First Post: 2007-03-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma
Sponsor: Fred Hutchinson Cancer Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None DS Stage I Plasma Cell Myeloma View
None DS Stage II Plasma Cell Myeloma View
None DS Stage III Plasma Cell Myeloma View
None Refractory Plasma Cell Myeloma View
Keywords: